Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Artrosilene
2. Lysyl-ketoprofen
1. Ketoprofen Lysinate
2. 57469-78-0
3. Ketoprofen Lysine Salt
4. Lysyl-ketoprofen
5. Artrosilene
6. Ketoprofen L-lysinate
7. Ketoprofen (lysinate)
8. L-lysine, Mono(3-benzoyl-alpha-methylbenzeneacetate)
9. 5wd00e3d4c
10. (s)-2,6-diaminohexanoic Acid Compound With 2-(3-benzoylphenyl)propanoic Acid (1:1)
11. 2-(3-benzoylphenyl)propanoic Acid;(2s)-2,6-diaminohexanoic Acid
12. Unii-5wd00e3d4c
13. Artrosilene (tn)
14. Schembl4623586
15. Chembl4650345
16. Hy-b0227a
17. Ketoprofen Lysine [who-dd]
18. Ketoprofen Lysine Salt [mi]
19. Mfcd03701078
20. Akos025311486
21. As-17318
22. Cs-0137969
23. D08102
24. 469k780
25. Q27262959
26. L-lysine, 3-benzoyl-.alpha.-methylbenzeneacetate (1:1)
Molecular Weight | 400.5 g/mol |
---|---|
Molecular Formula | C22H28N2O5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 9 |
Exact Mass | 400.19982200 g/mol |
Monoisotopic Mass | 400.19982200 g/mol |
Topological Polar Surface Area | 144 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 437 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
About the Company : BEC Chemicals Pvt. Ltd., was founded by Late Mr. M. T. Shah in 1979 and is specialized in manufacturing of Active pharmaceutical Ingredients (API’s) and Intermediates. The compan...
About the Company : Clarochem Ireland Ltd is an APIs manufacturing plant, located in Damastown, near Dublin, with more than 43m3 of production capacity and vessels ranging from 30 to 8000 liters, acqu...
ABOUT THIS PAGE
A Ketoprofen Lysinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketoprofen Lysinate, including repackagers and relabelers. The FDA regulates Ketoprofen Lysinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketoprofen Lysinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ketoprofen Lysinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ketoprofen Lysinate supplier is an individual or a company that provides Ketoprofen Lysinate active pharmaceutical ingredient (API) or Ketoprofen Lysinate finished formulations upon request. The Ketoprofen Lysinate suppliers may include Ketoprofen Lysinate API manufacturers, exporters, distributors and traders.
click here to find a list of Ketoprofen Lysinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ketoprofen Lysinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ketoprofen Lysinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ketoprofen Lysinate GMP manufacturer or Ketoprofen Lysinate GMP API supplier for your needs.
A Ketoprofen Lysinate CoA (Certificate of Analysis) is a formal document that attests to Ketoprofen Lysinate's compliance with Ketoprofen Lysinate specifications and serves as a tool for batch-level quality control.
Ketoprofen Lysinate CoA mostly includes findings from lab analyses of a specific batch. For each Ketoprofen Lysinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ketoprofen Lysinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ketoprofen Lysinate EP), Ketoprofen Lysinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ketoprofen Lysinate USP).
LOOKING FOR A SUPPLIER?